Prognostic factors in plasma cell myeloma
- 31 October 1983
- journal article
- editorial
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 19 (10) , 1493-1495
- https://doi.org/10.1016/0277-5379(93)90023-x
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Flow cytometric analysis of DNA content of bone marrow cells in patients with plasma cell myeloma: clinical implicationsBlood, 1982
- Serum beta-2-microglobulin in multiple myeloma: Relation to presenting features and clinical statusEuropean Journal of Cancer and Clinical Oncology, 1982
- Ploidy and proliferative characteristics in monoclonal gammopathiesBlood, 1982
- Pretreatment tumor mass, cell kinetics, and prognosis in multiple myelomaBlood, 1980
- The Chemotherapy of Plasma-Cell Myeloma and the Incidence of Acute LeukemiaNew England Journal of Medicine, 1979
- Kappa and lambda light chain disease: survival rates and clinical manifestationsBlood, 1976
- A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survivalCancer, 1975
- Immunoglobulin synthesis and total body tumor cell number in IgG multiple myelomaJournal of Clinical Investigation, 1970
- Growth Rates and Responses to Treatment in Human MyelomatosisBritish Journal of Haematology, 1969